The emergence of the novel pathogenic coronavirus SARS-CoV-2 in 2020 rapidly escalated into a global crisis. Despite the official end of the pandemic, many questions regarding the virus itself and the intricate mechanisms of host cell infection remain unanswered. However, addressing these gaps is crucial for understanding the disease and mitigating the impact of potential future pandemics. Due to the rapid transmission of SARS-CoV-2, the continuous emergence of viral variants, and the long-term consequences of COVID-19, the search for effective therapeutics beyond the limitations of vaccines remains ongoing. In this doctoral research, we demonstrated the potential of thioredoxin mimetic (TXM) peptides, validating the efficacy of disulfide bond reduction strategies in combating redox-sensitive viruses. TXM peptides, which also exhibit antioxidant and anti-inflammatory properties, successfully inhibited the binding of the SARS-CoV-2 spike (S) protein to the ACE2 receptor and prevented cell fusion. Importantly, these peptides blocked viral entry into host cells across different SARS-CoV-2 variants and, beyond inhibiting SARS-CoV-2 pseudovirus entry, also impaired HIV pseudovirus infection, highlighting their broad-spectrum antiviral potential. To further investigate the structural rearrangements required for the transition of the SARS-CoV-2 S protein from its prefusion to postfusion conformation, we introduced substitutions and flexible peptide linkers in various domains of the S protein. By stabilizing or destabilizing specific regions, we demonstrated the functional significance of maintaining a properly assembled trimer and preserving the integrity of the SD1 region while confirming the role of the S1 subunit in this process. Our findings highlight the sensitivity of S protein cleavage by furin and link successful fusion to the importance of cleavage by TMPRSS2, which, in certain cases, can restore the fusogenic activity of the S protein. Furthermore, we expanded our research by studying the assembly and dynamics of the trimeric S protein. We demonstrated that mixed trimers composed of protomers with different mutations can form and that a single fully functional protomer is sufficient to drive successful cell fusion. Using extended incubation times, we further showed that in the presence of the TMPRSS2 protease, syncytia can form between S-expressing and receptor cells independently of the ACE2 receptor. Given the expression profiles of ACE2 and TMPRSS2, along with the extensive lung damage observed in severe cases of COVID-19, our findings emphasize the critical role of TMPRSS2 in viral fusion, regardless of ACE2 presence.
|